文献速递复苏、休克与脓毒症儿科与产科急症

儿童非创伤性院外心脏骤停中肾上腺素与高级气道干预成功实施的顺序

Sequence of Successful Epinephrine or Advanced Airway Interventions in Nontraumatic Pediatric Out-Of-Hospital Cardiac Arrest.
PubMed 文献 · Acad Emerg Med · 2026-01-01
一句话结论儿童非创伤性院外心脏骤停中,首成功肾上腺素与首成功高级气道管理的顺序与出院存活无显著相关。

该研究为复苏结局联盟流行病学登记-心脏骤停前瞻性数据库的二次分析,纳入2011-2015年美国及加拿大10个地区年龄<18岁的非创伤性院外心脏骤停且接受肾上腺素和/或高级气道管理的患儿。暴露为首个成功干预的顺序(肾上腺素优先 vs 高级气道优先),主要终点为出院存活。886例中肾上腺素优先558例(63.0%)、高级气道优先297例(33.5%)、同秒记录31例(3.5%)。两组出院存活无显著差异(OR 1.03,95%CI 0.69-1.52);肾上腺素优先组院前ROSC odds更高(OR 1.38,95%CI 1.06-1.80),但出院时良好功能结局odds更低(OR 0.32,95%CI 0.13-0.76)。

要点

  • 886例患儿中,首成功干预为肾上腺素者558例(63.0%),为高级气道管理(AAM)者297例(33.5%),同秒记录者31例(3.5%)。
  • 肾上腺素优先与AAM优先的出院存活无显著差异(OR 1.03,95%CI 0.69-1.52)。
  • 相对AAM优先,肾上腺素优先与院前ROSC odds更高相关(OR 1.38,95%CI 1.06-1.80)。
  • 相对AAM优先,肾上腺素优先与出院时良好功能结局(改良Rankin量表≤3)odds更低相关(OR 0.32,95%CI 0.13-0.76)。

适用人群与场景

  • 年龄<18岁的非创伤性院外心脏骤停患儿,且接受了肾上腺素和/或高级气道管理(气管插管或声门上气道)。
  • 数据来源为复苏结局联盟流行病学登记-心脏骤停前瞻性数据库,覆盖2011-2015年美国及加拿大10个地区。

研究设计与关键结果

  • 研究类型:复苏结局联盟流行病学登记-心脏骤停前瞻性数据库的二次分析,纳入886例患儿。
  • 暴露:首个成功干预的顺序(肾上腺素优先 vs 高级气道管理优先);采用倾向评分逆概率治疗加权调整组间差异,logistic回归比较结局。
  • 主要终点出院存活:肾上腺素优先组 vs 高级气道管理优先组 OR 1.03(95%CI 0.69-1.52),无显著差异。
  • 次要终点院前ROSC:肾上腺素优先组 vs 高级气道管理优先组 OR 1.38(95%CI 1.06-1.80)。
  • 次要终点出院时良好功能结局(改良Rankin量表≤3):肾上腺素优先组 vs 高级气道管理优先组 OR 0.32(95%CI 0.13-0.76)。

证据类型、等级与局限

  • 证据类型:前瞻性数据库的观察性二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该观察性研究显示,在儿童非创伤性院外心脏骤停中,首成功肾上腺素与首成功高级气道管理的顺序与出院存活无显著相关,不能据此推断顺序可改变出院存活。
  • 肾上腺素优先与院前ROSC odds更高相关(OR 1.38,95%CI 1.06-1.80),但与出院时良好功能结局odds更低相关(OR 0.32,95%CI 0.13-0.76)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The optimal sequence of epinephrine administration and advanced airway management (AAM) successfully delivered during pediatric out-of-hospital cardiac arrest (OHCA) is unclear. Our objective was to determine whether the sequence of first successful epinephrine administration and first successful AAM is associated with survival and functional outcomes in pediatric OHCA.

METHODS: We performed a secondary analysis of the Resuscitation Outcomes Consortium Epidemiologic Registry-Cardiac Arrest, a prospective database from 10 US and Canadian regions (2011-2015). We included children (age < 18 years) with non-traumatic OHCA who received epinephrine and/or AAM (endotracheal intubation or supraglottic airway). Our exposure was the sequence of first successful epinephrine administration versus first successful AAM (epinephrine-first or AAM-first). The primary outcome was survival at hospital discharge. Secondary outcomes were a favorable functional outcome at discharge (modified Rankin Scale ≤ 3) and return of spontaneous circulation (ROSC) at hospital arrival. We adjusted for group differences using inverse-probability-of-treatment weighting derived from a propensity score and compared outcomes with logistic regression.

RESULTS: Of 886 eligible patients, 297 (33.5%) received AAM as the first successful intervention, 558 (63.0%) received epinephrine as the first successful intervention, and 31 (3.5%) received these at the same recorded second. There was no significant difference in survival at discharge between the epinephrine-first and AAM-first groups (odds ratio [OR], 1.03; 95% confidence interval [CI], 0.69-1.52). Relative to the AAM-first group, the epinephrine-first group was associated with higher odds of ROSC at hospital arrival (OR, 1.38; 95% CI, 1.06-1.80) but lower odds of favorable functional outcome at hospital discharge (OR, 0.32; 95% CI, 0.13-0.76).

CONCLUSIONS: In this large observational study of pediatric OHCA, the observed sequence of first successful epinephrine administration and first successful AAM was not associated with survival to hospital discharge.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Amagasa S, Utsumi S, Uematsu S, et al. Sequence of Successful Epinephrine or Advanced Airway Interventions in Nontraumatic Pediatric Out-Of-Hospital Cardiac Arrest. Acad Emerg Med. 2026. PMID: 41587366. doi:10.1111/acem.70225

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。